CCR5 and infection: Using the same approach, Didigu et al. showed that simultaneous genetic modification of CCR5 and CXCR4 in primary human CD4+ T cells rendered cells resistant to infection with R5- and X4-tropic HIV-1 strains in vitro and in vivo [17].